Presseportal.ch - Sanofi Pasteur MSD GmbH

GARDASIL® 9: 2-dose Schedule Approved in Europe

info@newsaktuell.ch (presseportal.ch) — Thu, 07 Apr 2016 09:03:27 +0200

Sanofi Pasteur MSD GmbH [Newsroom]
Lyon, France (ots/PRNewswire) - The European Commission granted marketing authorization for a two-dose schedule in 9-14 year old girls and boys for GARDASIL®9, the 9-valent HPV vaccine Sanofi Pasteur MSD announced today that the European Commission ... Lesen Sie hier weiter...

Sanofi Pasteur MSD Welcomes European Initiatives to set Vaccination as Standard of Prevention in Seniors

info@newsaktuell.ch (presseportal.ch) — Mon, 22 Feb 2016 09:02:13 +0100

Sanofi Pasteur MSD GmbH [Newsroom]
Lyon, France (ots/PRNewswire) - Results of review-based evidence on the public healthvalue of vaccination for seniors in Europe presented at WAidid congress The first Biennial Congress of the World Association for Infectious Diseases and ... Lesen Sie hier weiter...

Vaxelis®, New Fully-liquid Paediatric Hexavalent Vaccine Approved in the European Union

info@newsaktuell.ch (presseportal.ch) — Fri, 19 Feb 2016 09:02:04 +0100

Sanofi Pasteur MSD GmbH [Newsroom]
Lyon, France (ots/PRNewswire) - This decision opens the way to making Vaxelis® available to infants and toddlers in European countries Sanofi Pasteur MSD announced today that the European Commission has granted the marketing authorization for ... Lesen Sie hier weiter...

Human Papillomavirus Vaccines: The European Medicines Agency Safety Committee Concludes That Evidence Does Not Support That HPV Vaccines Cause CRPS or POTS

info@newsaktuell.ch (presseportal.ch) — Thu, 05 Nov 2015 17:28:01 +0100

Sanofi Pasteur MSD GmbH [Newsroom]
Lyon, France (ots/PRNewswire) - The European Medicine Agency's Pharmacovigilance Risk Assessment Committee (PRAC) concludes that there is no reason to change the way the vaccines are used or amend the current product information. Sanofi Pasteur MSD ... Lesen Sie hier weiter...

Sanofi Pasteur MSD Welcomes the Publication of a Special Issue on the Economic Value of Vaccination

info@newsaktuell.ch (presseportal.ch) — Thu, 17 Sep 2015 09:01:58 +0200

Sanofi Pasteur MSD GmbH [Newsroom]
Lyon, France (ots/PRNewswire) - A relevant and comprehensive approach on the benefits of vaccines on healthcare systems sustainability and economic growth Sanofi Pasteur MSD is proud to announce the publication of a supplement dedicated to the ... Lesen Sie hier weiter...

Sanofi Pasteur and Merck Vaccines Appoint David Khougazian as President of Sanofi Pasteur MSD

info@newsaktuell.ch (presseportal.ch) — Mon, 29 Jun 2015 14:01:59 +0200

Sanofi Pasteur MSD GmbH [Newsroom]
Lyon, France (ots/PRNewswire) - MSD, known as Merck in the United States and Canada and Sanofi Pasteur, the vaccines division of Sanofi , the two partner companies in Sanofi Pasteur MSD, announce today the appointment of David Khougazian as ... Lesen Sie hier weiter...

Sanofi Pasteur MSD : GARDASIL®9: New HPV Vaccine Approved in the European Union

info@newsaktuell.ch (presseportal.ch) — Wed, 17 Jun 2015 09:02:08 +0200

Sanofi Pasteur MSD GmbH [Newsroom]
Lyon, France (ots/PRNewswire) - The European Commission grants marketing authorization for GARDASIL 9, the only 9-valent HPV vaccine Sanofi Pasteur MSD announced today that the European Commission has granted marketing authorization for GARDASIL 9. ... Lesen Sie hier weiter...

Sanofi Pasteur MSD Welcomes the 10 year Anniversary

info@newsaktuell.ch (presseportal.ch) — Mon, 20 Apr 2015 09:02:14 +0200

Sanofi Pasteur MSD GmbH [Newsroom]
Lyon, France (ots/PRNewswire) - European vaccine leader hosts events across the region to help raise awareness of immunization throughout life Sanofi Pasteur MSD welcomes the World Health Organization's European Immunization Week 2015 (EIW 2015) ... Lesen Sie hier weiter...

GARDASIL® 9, New HPV Vaccine from Sanofi Pasteur MSD Granted Positive Opinion by European Committee for Medicinal Products for Human Use

info@newsaktuell.ch (presseportal.ch) — Fri, 27 Mar 2015 14:03:34 +0100

Sanofi Pasteur MSD GmbH [Newsroom]
Lyon, France (ots/PRNewswire) - European Committee for Medicinal Products for Human Use (CHMP) granted positive opinion for GARDASIL 9, the first 9-valent HPV vaccine Sanofi Pasteur MSD today announced that the Committee for Medicinal Products for ... Lesen Sie hier weiter...

European Commission Grants "2+1 Immunization Schedule" for Hexyon® 6-in-1 Paediatric Vaccine

info@newsaktuell.ch (presseportal.ch) — Thu, 05 Mar 2015 09:02:26 +0100

Sanofi Pasteur MSD GmbH [Newsroom]
Lyon, France (ots/PRNewswire) - This decision opens the way to making Hexyon(R) available to more infantsin European countries Sanofi Pasteur MSD announced today that the European Commission has granted a new vaccination schedule of the 6-in-1 ... Lesen Sie hier weiter...

Sanofi Pasteur MSD Welcomes European Immunization Week 2014

info@newsaktuell.ch (presseportal.ch) — Tue, 22 Apr 2014 09:01:58 +0200

Gardasil®: New 2-dose Schedule Granted Positive CHMP Opinion for Europe's Leading HPV Vaccine

info@newsaktuell.ch (presseportal.ch) — Thu, 27 Feb 2014 09:02:20 +0100

Sanofi Pasteur MSD GmbH [Newsroom]
Lyon, France (ots/PRNewswire) - European Committee for Medicinal Products for Human Use evaluated positively a 2-dose schedule for Gardasil(R) in adolescents Sanofi Pasteur MSD announced today that its quadrivalent HPV vaccine, Gardasil(R) has ... Lesen Sie hier weiter...

French National Health Authority Recommends Routine Vaccination with Zostavax® to Protect Seniors Against Shingles

info@newsaktuell.ch (presseportal.ch) — Wed, 18 Dec 2013 09:02:44 +0100

Sanofi Pasteur MSD GmbH [Newsroom]
Lyon, France (ots/PRNewswire) - France becomes second European country after the UK to provide nation-wide recommendation for zoster vaccination. The French National High Council for Public Health (HCSP) has recommended routine shingles vaccination ... Lesen Sie hier weiter...

Pivotal Study of Investigational 9-Valent HPV Vaccine Demonstrates Additional Protection Against HPV-Related Disease

info@newsaktuell.ch (presseportal.ch) — Mon, 04 Nov 2013 13:31:42 +0100

Sanofi Pasteur MSD GmbH [Newsroom]
Lyon, France (ots/PRNewswire) - - New 9-valent HPV vaccine prevented 97% of cervical, vaginal and vulvar pre-cancers caused by five additional HPV types - Immunogenicity non-inferior to GARDASIL for original four HPV types Lyon, 4 November 2013 - ... Lesen Sie hier weiter...

First Baby Vaccinated with Hexyon® in Europe

info@newsaktuell.ch (presseportal.ch) — Thu, 11 Jul 2013 09:02:52 +0200

Sanofi Pasteur MSD GmbH [Newsroom]
Lyon, France (ots/PRNewswire) - Germany first market in Europe to use innovative 6-in-1 paediatric vaccine Two month old baby Ben from Mönchengladbach, Germany, is the first infant in Europe to receive the new 6-in-1 paediatric vaccine Hexyon(R) ... Lesen Sie hier weiter...